To investigate this, MCF7 (ERα-positive) and MDA-MB-231 (triple-negative) breast cancer cell lines were chosen for proliferative and clonogenic survival analysis (Fig. 4a, b). This evidence concerns the gene ESR1 and breast carcinoma.